carmethizole has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, WK; Bhattacharjee, D; Houston, DM | 1 |
| Anderson, WK; Jarosinski, MA; Reddy, PS | 1 |
| Anderson, WK; Dykes, DJ; Griswold, DP; Harrison, SD; Plowman, J; Waud, WR | 1 |
3 other study(ies) available for carmethizole and B16 Melanoma
| Article | Year |
|---|---|
Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole.
Topics: Animals; Antineoplastic Agents; Carbamates; Chemical Phenomena; Chemistry; Drug Evaluation, Preclinical; Humans; Imidazoles; Leukemia, Experimental; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Structure-Activity Relationship | 1989 |
Synthesis, chemical reactivity, and antitumor evaluation of congeners of carmethizole hydrochloride, an experimental "acylated vinylogous carbinolamine" tumor inhibitor.
Topics: Alkylation; Animals; Antineoplastic Agents; Cell Division; Disulfides; Dose-Response Relationship, Drug; Imidazoles; Kinetics; Leukemia P388; Melanoma, Experimental; Mice; Neoplasm Transplantation; Oxygen; Rats; Sulfoxides | 1993 |
Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation, Preclinical; Drug Resistance; Humans; Imidazoles; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous | 1992 |